Stay updated with breaking news from Preclinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEWARK, Del.--(BUSINESS WIRE)--#HRMS--QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics in Europe. QPS annou...
Oxford-based SynaptixBio, whose aim is to find a treatment for TUBB4A-related leukodystrophies, has been awarded a £490,000 BioMedical Catalyst grant from Innovate UK to tackle less common variants of the disease. TUBB4A-related leukodystrophies are a group of rare neurodegenerative diseases primarily affecting ...
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The
Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen’s Third Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode.
Compugen Ltd. (NASDAQ:CGEN) Q3 2023 Earnings Call Transcript November 7, 2023 Compugen Ltd. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.09. Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen’s Third Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. As […]